1st September 2021
The Edinburgh Dysphagia Score (EDS) can support the assessment of patients with dysphagia by identifying patients at lowest risk of a malignant diagnosis, thereby allowing resources to be concentrated on those at highest risk.
In the original study, the EDS identified a group of patients at the highest risk of cancer; in this group the cancer yield at endoscopy was approximately 17-20%. Calculating the EDS therefore enables patients most at risk to be prioritised for endoscopy.
It is recommended that healthcare professionals act on any clinical suspicion and their decision to refer a patient should not be based on the EDS alone.
Find out more:
- Access GatewayC’s ‘Oesophageal Cancer – Early Diagnosis’ course here
- Read Urgent Cancer Diagnostic Services During Covid19 document here
- Read a guide to the Edinburgh Dysphagia Score document here
- Read GatewayC’s ‘4 tips to manage Barrett’s Oesophagus’ blog here